ChinaHealthcare and life sciences2026 – ongoingSinopharm
AI prescription screening with pharmacist final approval in Sichuan
Sinopharm reported over 70% higher prescription-review efficiency in a Sichuan pharmacy pilot
Problem
Pharmacies needed to assess appropriate medication use and medical-insurance compliance while managing review costs and workload.
Approach
Sinopharm's Sichuan operation worked with the group's digital technology unit to develop an AI screening agent. OCR and multimodal models parsed medical documents for initial checks. Pharmacists retained final approval in the pharmacy pilot.
Results
Takeaway
AI performed initial screening while pharmacists retained the final decision. Sinopharm did not disclose the test sample behind its accuracy claim.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and qualityFinance, risk and legal
- Innovation type
- Process innovation
- AI technology
- Generative AIComputer visionAI agents
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
Sinopharm described a pilot in 8 Sichuan pharmacies with AI initial screening and pharmacist final review. It reported over 70% higher review efficiency and over 90% accuracy in intercepting problematic prescriptions.
Full details are in the original sources.
